Abstract:A hyperexcitability of the motor system is consistently observed in Amyotrophic Lateral Sclerosis (ALS) and has been implicated in the disease pathogenesis. What drives this hyperexcitability in the vast majority of patients is unknown. This is important to know as existing treatments simply reduce all neuronal excitability and fail to distinguish between pathological changes and important homeostatic changes. Understanding what drives the initial pathological changes could therefore provide better treatments. One challenge is that patients represent a heterogeneous population and the vast majority of cases are sporadic. One pathological feature that almost all (~97%) cases (familial and sporadic) have in common is cytoplasmic aggregates of the protein TDP-43 which is normally located in the nucleus. In our experiments we investigated whether this pathology was sufficient to increase neuronal excitability and the mechanisms by which this occurs. We used the TDP-43(ΔNLS) mouse model which successfully recapitulates this pathology in a controllable way. We used in vivo intracellular recordings in this model to demonstrate that TDP-43 pathology is sufficient to drive a severe hyper-excitability of spinal motoneurones. Reductions in soma size and a lengthening and constriction of axon initial segments were observed, which would contribute to enhanced excitability. Resuppression of the transgene resulted in a return to normal excitability parameters by 6-8 weeks. We therefore conclude that TDP-43 pathology itself is sufficient to drive a severe but reversible hyperexcitability of spinal motoneurones.

What problem does this paper attempt to address?

### Problems the Paper Attempts to Solve This paper aims to explore whether TDP-43 pathology is sufficient to drive initial segment plasticity and hyperexcitability of spinal motor neurons, particularly in Amyotrophic Lateral Sclerosis (ALS). Specifically, the researchers aim to experimentally verify the following points: 1. **Whether TDP-43 pathology leads to hyperexcitability of spinal motor neurons**: Hyperexcitability of the motor system is commonly observed in ALS patients, and the driving mechanism of this phenomenon remains unclear in most cases. The researchers aim to understand whether TDP-43 pathology is the main cause of this phenomenon. 2. **The impact of TDP-43 pathology on neuronal structure**: The researchers also investigate whether TDP-43 pathology leads to structural changes such as reduced neuronal cell body size, elongated and thinned initial segment of the axon, which may further enhance neuronal excitability. 3. **Whether the excitability changes induced by TDP-43 pathology are reversible**: By inhibiting transgene expression, the researchers aim to determine whether the excitability changes induced by TDP-43 pathology can be reversed, thereby providing a basis for potential therapeutic strategies. ### Research Background - **Pathological features of ALS**: ALS is a fatal neurodegenerative disease, one of its main pathological features is the abnormal translocation of TDP-43 protein from the nucleus to the cytoplasm, forming phosphorylated and highly ubiquitinated aggregates. This pathological feature is observed in about 97% of ALS patients. - **Existing treatment methods**: Current treatment methods mainly aim to alleviate symptoms by reducing neuronal excitability, but this approach cannot distinguish between pathological excitability and normal homeostatic changes, thus its effectiveness is limited. - **Relationship between TDP-43 and excitability**: Previous studies have suggested that TDP-43 pathology may be related to changes in neuronal excitability, but these studies are mostly based on in vitro experiments and lack in vivo evidence. ### Experimental Methods - **TDP-43(ΔNLS) mouse model**: The researchers used a TDP-43(ΔNLS) mouse model, which removes the nuclear localization signal of TDP-43, causing it to translocate from the nucleus to the cytoplasm in adulthood, thereby mimicking the pathological features of ALS. - **In vivo electrophysiological recording**: The researchers conducted in vivo single-cell electrophysiological recordings to measure the excitability parameters of spinal motor neurons in different experimental groups of mice, including the current intensity required to induce repetitive firing (rheobase), instantaneous firing frequency, and gain. - **Anatomical analysis**: The researchers also used immunohistochemistry to analyze structural changes in spinal motor neurons, such as cell body size, initial segment length, and diameter of the axon. ### Main Findings - **TDP-43 pathology leads to hyperexcitability**: Spinal motor neurons in the TDP-43(ΔNLS) mouse model exhibited significant hyperexcitability, characterized by a significantly reduced rheobase, increased gain, and a lower threshold for secondary range firing frequency. - **Structural changes**: TDP-43 pathology also led to reduced cell body size, elongated and thinned initial segment of the axon in spinal motor neurons, which further enhanced neuronal excitability. - **Reversibility**: By inhibiting transgene expression, both the excitability changes and structural changes induced by TDP-43 pathology could be reversed, indicating that these changes are reversible. ### Conclusion The research results indicate that TDP-43 pathology alone is sufficient to drive hyperexcitability of spinal motor neurons, and these changes are reversible. This finding provides an important theoretical basis for developing targeted therapies against TDP-43 pathology.

TDP-43 pathology is sufficient to drive axon initial segment plasticity and hyperexcitability of spinal motoneurones in vivo in the TDP43-ΔNLS model of Amyotrophic Lateral Sclerosis

Axonal TDP-43 condensates drive neuromuscular junction disruption through inhibition of local synthesis of nuclear encoded mitochondrial proteins

Hyperexcitability precedes CA3 hippocampal neurodegeneration in a dox-regulatable TDP-43 mouse model of ALS-FTD.

TDP-43 pathology links innate and adaptive immunity in amyotrophic lateral sclerosis

ALS-linked mutant TDP-43 in oligodendrocytes induces oligodendrocyte damage and exacerbates motor dysfunction in mice

An ALS-linked mutation in TDP-43 disrupts normal protein interactions in the motor neuron response to oxidative stress

Homozygous ALS-linked mutations in TARDBP/TDP-43 lead to hypoactivity and synaptic abnormalities in human iPSC-derived motor neurons

Single-copy expression of an amyotrophic lateral sclerosis-linked TDP-43 mutation (M337V) in BAC transgenic mice leads to altered stress granule dynamics and progressive motor dysfunction

Rebalancing the motor circuit restores movement in a model for TDP-43-toxicity

Loss of TDP-43 in astrocytes leads to motor deficits by triggering A1-like reactive phenotype and triglial dysfunction

Human Motor Neurons Elicit Pathological Hallmarks of ALS and Reveal Potential Biomarkers of the Disease in Response to Prolonged IFNγ Exposure

CK1δ/ε-mediated TDP-43 phosphorylation contributes to early motor neuron disease toxicity in amyotrophic lateral sclerosis

Modeling hallmark pathology using motor neurons derived from the family and sporadic amyotrophic lateral sclerosis patient-specific iPS cells

TDP43 autoregulation gives rise to shortened isoforms that are tightly controlled by both transcriptional and post-translational mechanisms

Reduced STMN2 and pathogenic TDP-43, two hallmarks of ALS, synergize to accelerate motor decline in mice

Identifying the primary site of pathogenesis in amyotrophic lateral sclerosis - vulnerability of lower motor neurons to proximal excitotoxicity

Restricted expression of mutant SOD1 in spinal motor neurons and interneurons induces motor neuron pathology.

Hyperexcitability in Cultured Cortical Neuron Networks from the G93A-SOD1 Amyotrophic Lateral Sclerosis Model Mouse and its Molecular Correlates

A TDP-43 acetylation-mimic mutation that disrupts RNA-binding drives FTLD-like neurodegeneration in a mouse model of sporadic TDP-43 proteinopathy

Highly variable molecular signatures of TDP-43 loss of function are associated with nuclear pore complex injury in a population study of sporadic ALS patient iPSNs

Endogenous TDP-43 mislocalization in a novel knock-in mouse model reveals DNA repair impairment, inflammation, and neuronal senescence